CanSino Biologics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,337	1,329	2,023	2,822	3,465	5,645
Short-Term Investments	-	326.32	-	-	-	275.2
Trading Asset Securities	506.38	987.97	1,182	1,308	2,482	1,862
Cash & Short-Term Investments	1,844	2,644	3,204	4,130	5,947	7,783
Cash Growth	-43.67%	-17.50%	-22.41%	-30.55%	-23.59%	52.19%
Accounts Receivable	959.99	782.88	737.62	636.88	855.49	157.93
Other Receivables	5.48	4.9	10	3.98	0.54	19.15
Receivables	965.47	787.79	747.62	640.87	856.03	177.08
Inventory	387.74	347.85	283.41	352.85	677.78	875.62
Prepaid Expenses	-	-	-	0.25	-	-
Other Current Assets	32.99	59.45	47.08	57	249.59	454.49
Total Current Assets	3,230	3,839	4,282	5,181	7,730	9,290
Property, Plant & Equipment	2,563	2,611	2,641	3,013	3,069	2,218
Long-Term Investments	174.95	162.09	483.71	446.56	50.12	45.31
Other Intangible Assets	244.32	188.75	115.49	144.15	220.92	172.12
Long-Term Deferred Tax Assets	204.79	211.55	205.39	207.86	196.41	-
Long-Term Deferred Charges	79.77	137.93	172.21	88.4	51.95	26.19
Other Long-Term Assets	327.94	27.34	57.99	237.53	150.37	122.42
Total Assets	6,825	7,178	7,958	9,319	11,469	11,874

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	43.77	50.44	62.47	103.97	253.12	842.57
Accrued Expenses	120.5	456.29	400.08	453.14	407.25	362.44
Short-Term Debt	20	73.22	377.35	883.97	1,530	990.68
Current Portion of Long-Term Debt	-	245.31	514.82	510.59	45.77	90.11
Current Portion of Leases	-	5.43	9.99	64.63	48.76	31.18
Current Income Taxes Payable	-	5.12	4.66	0.54	3	29.14
Current Unearned Revenue	20.96	18.23	14.69	3.57	1.48	193.22
Other Current Liabilities	530.31	190.98	302.68	544.9	635.52	322.08
Total Current Liabilities	735.55	1,045	1,687	2,565	2,925	2,861
Long-Term Debt	900.21	956.95	1,099	1,066	878.01	40
Long-Term Leases	9.29	7.62	12.68	175.18	198.29	222.85
Long-Term Unearned Revenue	202.19	214.38	250.3	216.72	222.35	201.48
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.56
Other Long-Term Liabilities	-	-	-	8.49	-	-
Total Liabilities	1,847	2,224	3,048	4,031	4,223	3,326

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	247.04	247.04	247.45	247.45	247.45	247.45
Additional Paid-In Capital	5,190	5,165	6,577	6,574	6,608	6,598
Retained Earnings	-459.8	-459.08	-1,819	-1,440	42.71	1,150
Treasury Stock	-	-	-95.62	-106.17	-150.17	-
Comprehensive Income & Other	0.19	0.19	0.22	-0.18	0.12	-
Total Common Equity	4,978	4,954	4,910	5,275	6,748	7,995
Minority Interest	-	-	-	12.81	497.51	552.84
Shareholders' Equity	4,978	4,954	4,910	5,287	7,246	8,548
Total Liabilities & Equity	6,825	7,178	7,958	9,319	11,469	11,874

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	929.5	1,289	2,013	2,700	2,701	1,375
Net Cash (Debt)	914.25	1,355	1,191	1,430	3,246	6,408
Net Cash Growth	-33.96%	13.79%	-16.70%	-55.95%	-49.34%	28.90%
Net Cash Per Share	-	5.35	4.81	5.80	13.14	25.91
Filing Date Shares Outstanding	-	247.04	249.18	247.04	246.77	247.45
Total Common Shares Outstanding	-	247.04	249.18	247.04	246.77	247.45
Working Capital	2,494	2,794	2,596	2,616	4,805	6,428
Book Value Per Share	-	20.05	19.70	21.35	27.35	32.31
Tangible Book Value	4,734	4,765	4,794	5,130	6,527	7,823
Tangible Book Value Per Share	-	19.29	19.24	20.77	26.45	31.61
Buildings	-	1,294	1,025	978.89	729.03	724.68
Machinery	-	878.09	773.61	1,189	1,050	537.75
Construction In Progress	-	1,021	1,268	1,114	1,342	820.8